102 related articles for article (PubMed ID: 12533035)
1. Primary cutaneous follicle center cell lymphoma and limited stage follicular non-Hodgkin's lymphoma: a comparison of clinical and biological features.
Anghel G; Pulsoni A; De Rosa L
Leuk Lymphoma; 2002 Nov; 43(11):2109-15. PubMed ID: 12533035
[TBL] [Abstract][Full Text] [Related]
2. [Primary centrofollicular cutaneous cell lymphoma. Clinical description, treatment results, and follow up of 21 cases].
Anghel G; De Rosa L; Pulsoni A
Recenti Prog Med; 2002 Nov; 93(11):617-22. PubMed ID: 12489480
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity.
Goodlad JR; Krajewski AS; Batstone PJ; McKay P; White JM; Benton EC; Kavanagh GM; Lucraft HH;
Am J Surg Pathol; 2002 Jun; 26(6):733-41. PubMed ID: 12023577
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in stage I-III follicular non-Hodgkin lymphoma. Retrospective analysis of a series of 50 patients.
Fakhrian K; Klemm S; Keller U; Bayer C; Riedl W; Molls M; Geinitz H
Strahlenther Onkol; 2012 Jun; 188(6):464-70. PubMed ID: 22349634
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Sarris AH; Braunschweig I; Medeiros LJ; Duvic M; Ha CS; Rodriguez MA; Hagemeister FB; McLaughlin P; Romaguera J; Cox J; Cabanillas F
J Clin Oncol; 2001 Jan; 19(2):398-405. PubMed ID: 11208831
[TBL] [Abstract][Full Text] [Related]
7. Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Tezcan H; Vose JM; Bast M; Bierman PJ; Kessinger A; Armitage JO
Leuk Lymphoma; 1999 Jul; 34(3-4):273-85. PubMed ID: 10439364
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
[TBL] [Abstract][Full Text] [Related]
10. Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
Weinberg OK; Ma L; Seo K; Beck AH; Pai RK; Morales A; Kim Y; Sundram U; Tan D; Horning SJ; Hoppe RT; Natkunam Y; Arber DA
Am J Surg Pathol; 2009 Apr; 33(4):591-8. PubMed ID: 19065102
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
Barzenje DA; Cvancarova Småstuen M; Liestøl K; Fosså A; Delabie J; Kolstad A; Holte H
PLoS One; 2015; 10(7):e0131158. PubMed ID: 26147646
[TBL] [Abstract][Full Text] [Related]
13. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.
Lazzarino M; Orlandi E; Paulli M; Sträter J; Klersy C; Gianelli U; Gargantini L; Rousset MT; Gambacorta M; Marra E; Lavabre-Bertrand T; Magrini U; Manegold C; Bernasconi C; Möller P
J Clin Oncol; 1997 Apr; 15(4):1646-53. PubMed ID: 9193365
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
[TBL] [Abstract][Full Text] [Related]
16. Assessment of prognostic factors in follicular lymphoma patients.
Kondo E; Ogura M; Kagami Y; Taji H; Miura K; Takeuchi T; Maeda S; Asakura S; Suzuki R; Nakamura S; Morishima Y
Int J Hematol; 2001 Apr; 73(3):363-8. PubMed ID: 11345204
[TBL] [Abstract][Full Text] [Related]
17. Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy.
Mian M; Ferreri AJ; Rossi A; Conconi A; Tsang R; Gospodarowicz MK; Oldani E; Federico M; Luminari S; Pogliani EM; Rossini F; Cabrera ME; Martelli M; Gutierrez-Garcia G; Busetto M; Cavalli F; Zucca E; Rambaldi A; Cortelazzo S;
Leuk Lymphoma; 2013 Jan; 54(1):62-8. PubMed ID: 22784364
[TBL] [Abstract][Full Text] [Related]
18. Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: a study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept.
Aigner F; Korol D; Schmitt AM; Kurrer MO
Histopathology; 2012 Apr; 60(5):774-84. PubMed ID: 22304695
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M
Lancet Oncol; 2008 Apr; 9(4):352-8. PubMed ID: 18342572
[TBL] [Abstract][Full Text] [Related]
20. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
Fernández de Larrea C; Martínez-Pozo A; Mercadal S; García A; Gutierrez-García G; Valera A; Ghita G; Colomo L; Gainza E; Villamor N; Nomdedeu B; Estrach T; Montserrat E; Campo E; López-Guillermo A
Br J Haematol; 2011 May; 153(3):334-40. PubMed ID: 21375524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
